共 154 条
[1]
Brooks AN(2012)Molecular pathways: fibroblast growth factor signaling: a new therapeutic opportunity in cancer Clin Cancer Res 18 1855-1862
[2]
Kilgour E(2006)Ethnic differences in response to epidermal growth factor receptor tyrosine kinase inhibitors J Clin Oncol 24 2158-2163
[3]
Smith PD(2006)HER2 mutation and response to trastuzumab therapy in non-small-cell lung cancer N Engl J Med 354 2619-2621
[4]
Calvo E(2014)Correlation of EGFR mutation and histological subtype according to the IASLC/ATS/ERS classification of lung adenocarcinoma Int J Clin Exp Pathol 7 8039-8045
[5]
Baselga J(2009)The new lung cancer staging system Chest 136 260-271
[6]
Cappuzzo F(2009)New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 45 228-247
[7]
Bemis L(2013)Prognostic significance of the IASLC/ATS/ERS classification in Chinese patients—a single institution retrospective study of 292 lung adenocarcinoma J Surg Oncol 107 474-480
[8]
Varella-Garcia M(2013)Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification on death and recurrence in completely resected stage I lung adenocarcinoma Ann Surg 258 1079-1086
[9]
Chen Z(2011)Global cancer statistics CA Cancer J Clin 61 69-90
[10]
Liu X(2010)Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer N Engl J Med 363 1693-1703